Literature DB >> 6214626

Claimants for mobility allowance: causes of disability and the scope for prevention.

G M Robertson.   

Abstract

Six hundred and twenty-one claimants for Mobility Allowance were examined by the author, who recorded the patient's statement of his or her history and current disability, carried out a full physical examination and observed the gait and limitation of walking. Four hundred and seventy-five appeared to satisfy the medical conditions to qualify for the allowance. They were analysed by age, sex and body system involved and were compared with the corresponding total figure for Mobility Allowance in England, Scotland and Wales.The more common diagnoses are listed and are considered from the point of view of prevention. The implications for general practice are discussed. They concern the detection of hypertension and health education for antenatal care, smoking and the wearing of seat belts.

Entities:  

Mesh:

Year:  1982        PMID: 6214626      PMCID: PMC1972509     

Source DB:  PubMed          Journal:  J R Coll Gen Pract        ISSN: 0035-8797


  4 in total

1.  An epidemiological study of cerebral palsy in Western Australia, 1956-1975. I: Changes in total incidence of cerebral palsy and associated factors.

Authors:  F J Stanley
Journal:  Dev Med Child Neurol       Date:  1979-12       Impact factor: 5.449

2.  Increased risk of recurrence of pregnancies complicated by fetal neural tube defects in mothers receiving poor diets, and possible benefit of dietary counselling.

Authors:  K M Laurence; N James; M Miller; H Campbell
Journal:  Br Med J       Date:  1980-12-13

3.  Control of road trauma epidemic in Australia.

Authors:  F McDermott
Journal:  Ann R Coll Surg Engl       Date:  1978-11       Impact factor: 1.891

4.  Possible prevention of neural-tube defects by periconceptional vitamin supplementation.

Authors:  R W Smithells; S Sheppard; C J Schorah; M J Seller; N C Nevin; R Harris; A P Read; D W Fielding
Journal:  Lancet       Date:  1980-02-16       Impact factor: 79.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.